StarZero All shows Try the podcast clipper →

biotech industry

7 statements across 4 episodes · 2 bullish · 2 bearish · 4 people on the record · first statement Jan 2, 2019 by Jorge Conde · across every show →

Everything said about biotech industry, oldest first

Jan 2, 2019 bullish
Insight
Conde: Engineering principles make later drug programs more valuable than earlier ones
“The second drug is more valuable than the first if you're using engineering principles, because what you learn from example one sort of imbues value to example two and so on and so forth.”
Jorge Conde Jan 2, 2019 ▶ 8:34 a16z Podcast | When (and How) Biology Becomes Engineering
Feb 28, 2019
Assertion Contradicted
Nate Chang: Biotech M&A deals totaled $123 billion in 2018
“So in 2018, the industry announced one hundred twenty three billion of MNA transactions.”
Nate Chang Feb 28, 2019 ▶ 9:23 What’s with All the Bio M&A in 2019?: A Quick Take
Feb 28, 2019
Assertion Supported
Nate Chang: Biotech M&A reached $94 billion by early 2019
“This year we're at ninety four billion.”
Nate Chang Feb 28, 2019 ▶ 9:30 What’s with All the Bio M&A in 2019?: A Quick Take
Apr 30, 2025
Assertion Not checkable as stated
Biotech funding cycle has shifted away from platforms back to products
“I think the pendulum always swings back and forth between platforms and products and back again. I think we're back in the product cycle”
Jonathan Lim Apr 30, 2025 ▶ 19:10 Biotech CEO on where we are in the fight to cure cancer
Nov 14, 2025 bullish
Prediction Not checkable as stated
Nuzhna: Everyone in biotech will use AI within five years
“Everyone will be using AI and biotech industry five years from now.”
Lada Nuzhna Nov 14, 2025 ▶ 0:27 The Brutal Truth About Biotech: Why $2B Per Drug Is Killing Innovation
Nov 14, 2025 negative
Assertion Contradicted
Nuzhna: FDA regulation has continuously increased except during the AIDS crisis
“Since the birth of this industry, we only had increasing regulation over time. I think there was like only one time in history of biotech where we made it easier to develop and approve new drugs. And that was during the ACE crisis where AIDS patients were just…”
Lada Nuzhna Nov 14, 2025 ▶ 6:15 The Brutal Truth About Biotech: Why $2B Per Drug Is Killing Innovation
Nov 14, 2025 negative
Assertion Not checkable as stated
Nuzhna: Biotech regulatory requirements have continuously increased since industry inception
“Since the birth of this industry, we only had increasing regulation over time.”
Lada Nuzhna Nov 14, 2025 ▶ 6:16 The Brutal Truth About Biotech: Why $2B Per Drug Is Killing Innovation
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 1,000 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.

Try the podcast clipper Learn more